{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:51:44Z","timestamp":1762300304416},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data exist about the implementation of this strategy in older adults from routine clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a Spanish multicentre, retrospective, observational registry-based study that included patients with ACS but no thrombotic or bleeding events during the first year of DAPT after discharge and no indication for oral anticoagulants. High bleeding risk was defined according to the Academic Research Consortium definition. We assessed the proportion of cases of extended DAPT among patients 65\u2009\u2265\u2009years that went beyond 1 year after hospitalisation for ACS and the variables associated with the strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that 48.1% (928\/1,928) of patients were aged\u2009\u2265\u200965 years. DAPT was continued beyond 1 year in 32.1% (298\/928) of patients\u2009\u2265\u200965; which was a similar proportion as with their younger counterparts. There was no significant correlation between a high bleeding risk and DAPT duration. Contrastingly, there was a strong correlation between the extent of coronary disease and DAPT duration (p\u2009&lt;\u20090.001). Other variables associated with extended DAPT were a higher left ventricle ejection fraction, a history of heart failure and a prior stent thrombosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There was no correlation between age and extended use of DAPT beyond 1 year in older patients with ACS. DAPT was extended in about one-third of patients\u2009\u2265\u200965 years. The severity of the coronary disease, prior heart failure, left ventricle ejection fraction and prior stent thrombosis all correlated with extended DAPT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-023-00476-5","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:11:47Z","timestamp":1679865107000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Albert","family":"Ariza-Sol\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Mateus-Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Formiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Garcia-Blas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Bonanad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"N\u00fa\u00f1ez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vergara-Uzcategui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"D\u00edez-Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ba\u00f1eras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Badia-Molins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Aboal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Carreras-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gabald\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Parada-Barcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Mart\u00ednez-Sell\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Com\u00edn-Colet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"476_CR1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM. DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155\u201366.","journal-title":"N Engl J Med"},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, J\u00fcni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"476_CR3","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/jcm11061680","volume":"11","author":"C Bonanad","year":"2022","unstructured":"Bonanad C, Raposeiras-Roubin S, Garc\u00eda-Blas S, N\u00fa\u00f1ez-Gil I, Vergara-Uzcategui C, D\u00edez-Villanueva P, Ba\u00f1eras J, Bad\u00eda Molins C, Aboal J, Carreras J, Bodi V, Gabald\u00f3n-P\u00e9rez A, Mateus-Porta G, Parada Barcia JA, Mart\u00ednez-Sell\u00e9s M, Chorro FJ. Ariza-Sol\u00e9 A. evaluation of the use of dual antiplatelet therapy beyond the first year after acute coronary syndrome. J Clin Med. 2022;11:1680.","journal-title":"J Clin Med"},{"key":"476_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.recesp.2013.01.019","volume":"66","author":"IR D\u00e9gano","year":"2013","unstructured":"D\u00e9gano IR, Elosua R, Marrugat J. Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049. Rev Esp Cardiol. 2013;66:472\u201381.","journal-title":"Rev Esp Cardiol"},{"key":"476_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1055\/s-0038-1635259","volume":"118","author":"A Garay","year":"2018","unstructured":"Garay A, Ariza-Sol\u00e9 A, Formiga F, Raposeiras-Roub\u00edn S, Abu-Assi E, S\u00e1nchez-Salado JC, Lorente V, Alegre O, Henriques JPS, D\u2019Ascenzo F, Saucedo J, Gonz\u00e1lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu\u00f1ez-Gil I, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc\u00eda-Acu\u00f1a JM, Southern D, Alfonso E, Terol B, Zhang D, Chen Y, Xanthopoulou I, Osman N, M\u00f6llmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Cequier A. Prediction of post-discharge bleeding in elderly patients with acute coronary syndromes: insights from the BleeMACS registry. Thromb Haemost. 2018;118:929\u201338.","journal-title":"Thromb Haemost"},{"key":"476_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0002-8703(03)00408-3","volume":"146","author":"HM Krumholz","year":"2003","unstructured":"Krumholz HM, Gross CP, Peterson ED, Barron HV, Radford MJ, Parsons LS, Every NR. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J. 2003;146:839\u201347.","journal-title":"Am Heart J"},{"key":"476_CR7","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1161\/CIRCULATIONAHA.111.025452","volume":"124","author":"N Ekerstad","year":"2011","unstructured":"Ekerstad N, Swahn E, Janzon M, Alfredsson J, L\u00f6fmark R, Lindenberger M, Carlsson P. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation. 2011;124:2397\u2013404.","journal-title":"Circulation"},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bcp.14213","volume":"86","author":"JM Ruiz-Nodar","year":"2020","unstructured":"Ruiz-Nodar JM, Esteve-Pastor MA, Rivera-Caravaca JM, Sand\u00edn M, Lozano T, Vicente-Ibarra N, Orenes-Pi\u00f1ero E, Mac\u00edas MJ, Pern\u00edas V, Carrillo L, Candela E, Veliz A, Tello-Montoliu A, Mart\u00ednez Mart\u00ednez JG, Mar\u00edn F. One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: results from a prospective and multicentre ACHILLES registry. Br J Clin Pharmacol. 2020;86:1052\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"476_CR9","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS. PEGASUS-TIMI 54 Steering Committee and investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372:1791\u2013800.","journal-title":"N Engl J Med"},{"key":"476_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/2047487319836327","volume":"27","author":"F D\u2019Ascenzo","year":"2020","unstructured":"D\u2019Ascenzo F, Bertaina M, Fioravanti F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Sol\u00e9 A, Manzano-Fern\u00e1ndez S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omed\u00e8 P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fern\u00e1ndez MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Vald\u00e9s M, Cequier A, Alexopoulos D, I\u00f1iguez-Romo A, Gaita F, Rinaldi M, L\u00fcscher TF. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: insights from the RENAMI registry. Eur J Prev Cardiol. 2020;27:696\u2013705.","journal-title":"Eur J Prev Cardiol"},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12872-020-01780-y","volume":"21","author":"F Sanchez","year":"2021","unstructured":"Sanchez F, Boasi V, Vercellino M, Tacchi C, Cannarile P, Pingelli N, Perri D, Gomez L, Cattunar S, Mascelli G. Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a \u201creal world\u201d STEMI population: results from the italian \u201cCARDIO-STEMI SANREMO\u201d registry. BMC Cardiovasc Disord. 2021;21:144.","journal-title":"BMC Cardiovasc Disord"},{"key":"476_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/clc.23400","volume":"43","author":"B Zheng","year":"2020","unstructured":"Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso Garcia A, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Long-term antithrombotic management patterns in asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol. 2020;43:999\u20131008.","journal-title":"Clin Cardiol"},{"key":"476_CR13","doi-asserted-by":"crossref","unstructured":"Bardaj\u00ed A, Leal M, Arrarte V, Garcia-Moll X, P\u00e9rez de Isla L, Bueno H. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.Cardiovasc Ther. 2017;35.","DOI":"10.1111\/1755-5922.12237"},{"key":"476_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjcard.2018.11.051","volume":"123","author":"M Schoos","year":"2019","unstructured":"Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R. Patterns and impact of dual antiplatelet cessation on cardiovascular risk after percutaneous coronary intervention in patients with acute coronary syndromes. Am J Cardiol. 2019;123:709\u201316.","journal-title":"Am J Cardiol"},{"key":"476_CR15","doi-asserted-by":"publisher","first-page":"e0186961","DOI":"10.1371\/journal.pone.0186961","volume":"12","author":"G Patti","year":"2017","unstructured":"Patti G, Cavallari I, Antonucci E, Calabr\u00f2 P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R. Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome. PLoS ONE. 2017;12:e0186961.","journal-title":"PLoS ONE"},{"key":"476_CR16","doi-asserted-by":"crossref","unstructured":"Ariza-Sol\u00e9 A, Guerrero C, Formiga F, Aboal J, Abu-Assi E, Mar\u00edn F, Bueno H, Alegre O, L\u00f3pez-Palop R, Vid\u00e1n MT, Mart\u00ednez-Sell\u00e9s M, D\u00edez-Villanueva P, Vilardell P, Sionis A, Vives-Borr\u00e1s M, Sanch\u00eds J, Ba\u00f1eras J, Rafecas A, Llibre C, L\u00f3pez J, Gonz\u00e1lez-Salvado V, Cequier \u00c0. ; LONGEVO-SCA Registry Investigators. Global geriatric assessment and in-hospital bleeding risk in elderly patients with acute coronary syndromes: Insights from the LONGEVO-SCA registry.Thromb Haemost;118:581\u201390.","DOI":"10.1055\/s-0038-1623532"},{"key":"476_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.recesp.2018.01.012","volume":"72","author":"A Ariza-Sol\u00e9","year":"2019","unstructured":"Ariza-Sol\u00e9 A, Formiga F, Bardaj\u00ed A, Viana-Tejedor A, Alegre O, de Frutos F. Clinical characteristics and prognosis of very elderly patients with acute coronary syndrome treated with ticagrelor: insights from the LONGEVO-SCA registry. Rev Esp Cardiol. 2019;72:263\u201366.","journal-title":"Rev Esp Cardiol"},{"key":"476_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394.","journal-title":"J Am Geriatr Soc"},{"key":"476_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.recesp.2020.06.025","volume":"74","author":"J Sanchis","year":"2021","unstructured":"Sanchis J, Garc\u00eda Acu\u00f1a JM, Raposeiras S, Barrab\u00e9s JA, Cordero A, Mart\u00ednez-Sell\u00e9s M, Bardaj\u00ed A, D\u00edez-Villanueva P, Mar\u00edn F, Ruiz-Nodar JM, Vicente-Ibarra N, Alonso Salinas GL, Rigueiro P, Abu-Assi E, Formiga F, N\u00fa\u00f1ez J, N\u00fa\u00f1ez E. Ariza-Sol\u00e9 A. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome. Rev Esp Cardiol. 2021;74:765\u201372.","journal-title":"Rev Esp Cardiol"},{"key":"476_CR20","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.jacc.2021.04.016","volume":"77","author":"M Ono","year":"2021","unstructured":"Ono M, Serruys PW, Hara H, Kawashima H, Gao C, Wang R, Takahashi K, O\u2019Leary N, Wykrzykowska JJ, Sharif F, Piek JJ, Garg S, Mack MJ, Holmes DR, Morice MC, Head SJ, Kappetein AP, Thuijs DJFM, Noack T, Davierwala PM, Mohr FW, Cohen DJ, Onuma Y. SYNTAX extended Survival investigators. 10-year follow-up after revascularization in elderly patients with complex coronary artery disease. J Am Coll Cardiol. 2021;77:2761\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"476_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/eurheartj\/ehab391","volume":"43","author":"N Morici","year":"2022","unstructured":"Morici N, De Servi S, De Luca L, Crimi G, Montalto C, De Rosa R, De Luca G, Rubboli A, Valgimigli M, Savonitto S. Management of acute coronary syndromes in older adults. Eur Heart J. 2022;43:1542\u201353.","journal-title":"Eur Heart J"},{"key":"476_CR22","first-page":"114","volume":"16","author":"S Garc\u00eda-Blas","year":"2019","unstructured":"Garc\u00eda-Blas S, Bonanad C, Sanchis J. Invasive strategy in elderly patients with acute coronary syndrome in 2018: close to the truth? J Geriatr Cardiol. 2019;16:114\u201320.","journal-title":"J Geriatr Cardiol"},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/gerona\/glz123","volume":"75","author":"G Campo","year":"2020","unstructured":"Campo G, Maietti E, Tonet E, Biscaglia S, Ariza-Sol\u00e8 A, Pavasini R, Tebaldi M, Cimaglia P, Bugani G, Serenelli M, Ruggiero R, Vitali F, Formiga F, Sanchis J, Galvani M, Minarelli M, Lucchi GR, Ferrari R, Guralnik J, Volpato S. The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary dyndrome. J Gerontol A Biol Sci Med Sci. 2020;75:1113\u201319.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"476_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.clnu.2019.06.025","volume":"39","author":"E Tonet","year":"2020","unstructured":"Tonet E, Campo G, Maietti E, Formiga F, Martinez-Sell\u00e9s M, Pavasini R, Biscaglia S, Serenelli M, Sanchis J, Diez-Villanueva P, Bugani G, Vitali F, Ruggiero R, Cimaglia P, Bernucci D, Volpato S, Ferrari R, Ariza-Sol\u00e9 A. Nutritional status and all-cause mortality in older adults with acute coronary syndrome. Clin Nutr. 2020;39:1572\u201379.","journal-title":"Clin Nutr"},{"key":"476_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.amjcard.2019.07.003","volume":"124","author":"CS Kwok","year":"2019","unstructured":"Kwok CS, Lundberg G, Al-Faleh H, Sirker A, Van Spall HGC, Michos ED, Rashid M, Mohamed M, Bagur R, Mamas MA. Relation of frailty to outcomes in patients with acute coronary syndromes. Am J Cardiol. 2019;124:1002\u201311.","journal-title":"Am J Cardiol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-023-00476-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:14:03Z","timestamp":1679865243000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-023-00476-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s12959-023-00476-5","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Hospital Bellvitge de Barcelona Institutional Review Board (or Ethics Committee) (protocol code EPA002\/20 and date of approval: 27 February 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}